Cargando…
Low-Dose Radiation Reduces Doxorubicin-Induced Myocardial Injury Through Mitochondrial Pathways
The use of doxorubicin (DOX) as an anthraquinone antineoplastic agent is limited due to its cardiotoxicity. Our previous study suggested that low-dose radiation (LDR) could mitigate the cardiotoxicity induced by DOX via suppressing oxidative stress and cell apoptosis. However, the molecular targets...
Autores principales: | Zhao, Di, Jiang, Xin, Meng, Xinxin, Liu, Dandan, Du, Yanwei, Zhao, Lijing, Jiang, Hongyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926390/ https://www.ncbi.nlm.nih.gov/pubmed/36798636 http://dx.doi.org/10.1177/15593258231155789 |
Ejemplares similares
-
Low-Dose Radiation Enhanced Inhibition of Breast Tumor Xenograft and Reduced Myocardial Injury Induced by Doxorubicin
por: Jiang, Xin, et al.
Publicado: (2018) -
Low dose radiation prevents doxorubicin-induced cardiotoxicity
por: Jiang, Xin, et al.
Publicado: (2017) -
Naringin Interferes Doxorubicin-Induced Myocardial Injury by Promoting the Expression of ECHS1
por: Zhao, Zirui, et al.
Publicado: (2022) -
Fucoidan Protects against Doxorubicin-Induced Cardiotoxicity by Reducing Oxidative Stress and Preventing Mitochondrial Function Injury
por: Ji, Yuting, et al.
Publicado: (2022) -
Ultrasound-responsive highly biocompatible nanodroplets loaded with doxorubicin for tumor imaging and treatment in vivo
por: Zhou, Xiaoying, et al.
Publicado: (2020)